Diagnostic CT with low-dose radiation
Diagnostic TestEffective dose is aimed at approximately 2 millisievert (mSv) in an average patient.
Other names: Low-dose CT
NCT Number: NCT01925014
To determine whether low-dose (LD) CT is noninferior to standard-dose (SD) computed tomography (CT) as the first-line imaging test in adolescents and young adults in regard to negative appendectomy rate (NAR).
Looking for future studies?
Notify Me15 year–44 year
All sexes
Interventional
Not applicable
Kangwon National University Hospital, Chuncheon, Gangwon-do, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Effective dose is aimed at approximately 2 millisievert (mSv) in an average patient.
Other names: Low-dose CT
Effective dose is aimed at approximately 8 millisievert (or less) in an average patient.
Other names: Standard-dose CT
Time frame: 1 week after surgery
Negative appendectomy rate was defined as the percentage of negative (unnecessary) appendectomies among all non-incidental appendectomies. As a secondary analysis, negative appendectomy rate in an alternative definition was calculated by excluding cases with appendiceal neoplasms without superimposed appendicitis, as appendectomy would be clinically necessary in such patients. Any surgery performed for the treatment of presumed appendicitis was counted as non-incidental appendectomy, even though the surgical procedures were more extensive than simple appendectomy (e.g., ileocectomy).
Time frame: 1 week after surgery
The percentage of perforated appendicitis among confirmed appendicitis cases.
Time frame: 3 months after CT
Appendectomy rate. The percentage of appendectomies among all randomized cases.
Time frame: 1 week after surgery
The percentage of negative appendectomies among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
Time frame: 1 week after surgery
The percentage (i.e., prevalence) of perforated appendicitis among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
Time frame: 1 week after surgery
The percentage (i.e., prevalence) of non-perforated appendicitis among all randomized cases. In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies. Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
Time frame: 1 week after CT
The proportion of patients requiring additional imaging test(s) in order to diagnose or rule out appendicitis.
Time frame: 3 months after CT
Time frame: 3 months after CT
The interval from CT acquisition to hospital discharge after appendectomy.
Time frame: 3 months after CT
Time frame: 3 months after CT
Time frame: 3 months after CT
Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present.
Time frame: 3 months after CT
The frequency of indeterminate CT interpretation (grade 3). Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present.
Time frame: 3 months after CT
The frequency of normal appendix visualization at CT. Grade 0 denotes appendix not identified; grade 1, unsure or partly visualized; and grade 2, clearly and entirely visualized.
Time frame: 3 months after CT
Kyoung Ho Lee, MD
Other
A Multi-institutional Trial Comparing Clinical Outcomes Following Low- vs. Standard-dose Abdominal CT as the First-line Imaging Test in Adolescents and Young Adults With Suspected Acute Appendicitis
Acronym: LOCAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05002829
Appendicitis, Cecal Diseases
Denver, Colorado, United States
View Trial DetailsNCT05887414
Appendicitis, Cecal Diseases
Baldwin Park, California, United States
View Trial DetailsNCT05209061
Appendicitis, Cecal Diseases
Copenhagen, Denmark
View Trial DetailsNCT04986397
Appendicitis, Cecal Diseases
Boston, Massachusetts, United States
View Trial Details